The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
azepan-1-yl(4-(4-bromophenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl)methanone ID: ALA4557880
PubChem CID: 2915425
Max Phase: Preclinical
Molecular Formula: C25H27BrN2O
Molecular Weight: 451.41
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(c1ccc2c(c1)C1C=CCC1C(c1ccc(Br)cc1)N2)N1CCCCCC1
Standard InChI: InChI=1S/C25H27BrN2O/c26-19-11-8-17(9-12-19)24-21-7-5-6-20(21)22-16-18(10-13-23(22)27-24)25(29)28-14-3-1-2-4-15-28/h5-6,8-13,16,20-21,24,27H,1-4,7,14-15H2
Standard InChI Key: CRXMZSSIDMULFK-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
25.1157 -19.0610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9418 -19.0610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8627 -18.2758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5288 -17.7884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1943 -18.2759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9451 -17.9451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0368 -17.1257 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.6140 -16.9699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3689 -16.6415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4607 -15.8252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7984 -15.3364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0422 -15.6699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9540 -16.4853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3754 -15.1819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4645 -14.3606 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.6194 -15.5156 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.7643 -13.9284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6665 -13.1060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2421 -14.0861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2438 -12.5169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5105 -13.3032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0639 -12.6069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6110 -18.4342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5178 -19.2529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1827 -19.7419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9403 -19.4098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0287 -18.5841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3628 -18.0988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6067 -19.8982 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 5 1 0
4 3 1 0
3 1 2 0
4 5 1 0
4 8 1 0
5 6 1 0
6 7 1 0
7 9 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
12 14 1 0
14 15 1 0
14 16 2 0
15 17 1 0
17 18 1 0
15 19 1 0
18 20 1 0
19 21 1 0
20 22 1 0
21 22 1 0
6 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
26 29 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 451.41Molecular Weight (Monoisotopic): 450.1307AlogP: 6.29#Rotatable Bonds: 2Polar Surface Area: 32.34Molecular Species: NEUTRALHBA: 2HBD: 1#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 2.04CX LogP: 5.35CX LogD: 5.35Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.54Np Likeness Score: -0.85
References 1. (2012) Entpd5 inhibitors,